Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19
A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial
Stephen J. Balevic, Daniel K. Benjamin Jr, William G. Powderly, P. Brian Smith, Daniel Gonzalez, Matthew W. McCarthy, Linda K. Shaw, Christopher J. Lindsell, Sam Bozzette, Daphne Williams, Benjamin P. Linas, John Blamoun, Heta Javeri, Christoph P. Hornik, for the ACTIV-1 IM Study Group
Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
Juliet M. Flam-Ross, Elizabeth Marsh, Michelle Weitz, Alexandra Savinkina, Bruce R. Schackman, Jianing Wang, R. W. M. Madushani, Jake R. Morgan, Joshua A. Barocas, Alexander Y. Walley, Stavroula A. Chrysanthopoulou, Benjamin P. Linas, Sabrina A. Assoumou
The association between naloxone claims and proportion of independent vs. chain pharmacies: A longitudinal analysis of naloxone claims in the US
Christina E. Freibott, Ali Jalali, Sean M. Murphy, Alexander Y. Walley, Benjamin P Linas, Philip J Jeng, Jeffrey Bratberg, Brandon D.L. Marshall, Xiao Zang, Traci C Green, Jake R. Morgan
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
Avik Chatterjee, Michelle Weitz, Alexandra Savinkina, Alexandria Macmadu, R. W. M. A. Madushani, Ruth A. Potee, Danielle Ryan, Sean M. Murphy, Alexander Y. Walley, Benjamin P. Linas,
